Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The new biomaterial inspired by ancient Chinese medicine effectively promotes hair growth and heals wounds in burned skin.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Type I interferons play a key role in the development of various skin diseases.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

The new nanocomposite films are stronger, protect against UV, speed up wound healing, and are antibacterial without being toxic.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Fat stem cells from diabetic mice can still help heal wounds.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The SA-MS hydrogel is a promising material for improving wound healing and skin regeneration in diseases like diabetes and skin cancer.

Local injections of nanosized rhEPO can speed up skin healing and improve quality after deep second-degree burns.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.